(1 - 10 from 13
)
Brokerage Upgrades Teva Recommendation following ...jewishbusinessnews.com › › brokerage-upg...
jewishbusinessnews.com
... is mostly from mergers and acquisitions, ” Bank of Jerusalem Brokerage head of research Jonathan Kreizman writes today in his review.
UPDATE: Teva Buys Allergan for $40.5 Billion | The Jewish Press -...
www.jewishpress.com
UPDATE: Teva Buys Allergan for $40.5 Billion. By: JNi.Media. Published: July 27th, Bank of Jerusalem analyst Jonathan Kreizman said, “(Teva) ...
News - qbgroupwww.qbgroup.it › news
www.qbgroup.it
... to a hostile situation,” commented Bank of Jerusalem analyst Jonathan Kreizman, adding “Teva and Allergan have less overlap than Teva and Mylan.” Shares ...
sorted by relevance / date